Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant Recipients”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60
Not applicableStudy completedNCT01672957
What this trial is testing

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 128
Post-approval studies (Phase 4)Study completedNCT00492661
What this trial is testing

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

Who this might be right for
Renal TransplantionKidney Transplantion
Janssen-Cilag Pty Ltd 55
Large-scale testing (Phase 3)Study completedNCT00170833
What this trial is testing

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT00820911
What this trial is testing

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT02970630
What this trial is testing

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Who this might be right for
Kidney Transplantation
Chiesi Farmaceutici S.p.A. 28
Testing effectiveness (Phase 2)Study completedNCT00617604
What this trial is testing

Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Who this might be right for
De Novo Kidney Transplantation
Astellas Pharma Inc 218
Post-approval studies (Phase 4)Study completedNCT00507793
What this trial is testing

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 385
Large-scale testing (Phase 3)Study completedNCT00720265
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 135
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00239785
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Testing effectiveness (Phase 2)Study completedNCT00504543
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 311
Testing effectiveness (Phase 2)Study completedNCT01596062
What this trial is testing

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Post-approval studies (Phase 4)Study completedNCT00369161
What this trial is testing

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 228
Post-approval studies (Phase 4)Study completedNCT00862979
What this trial is testing

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Large-scale testing (Phase 3)Study completedNCT00239070
What this trial is testing

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 69
Post-approval studies (Phase 4)Study completedNCT00266123
What this trial is testing

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 420
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation